Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

2.
3.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

4.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

5.

Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.

Nihalani ND, Tu X, Lamberti JS, Olson D, Olivares T, Costea GO, Tang W.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):105-12. Review. Erratum in: Ann Clin Psychiatry. 2007 Oct-Dec;19(4):329. Tu, Xin [added].

PMID:
17612850
6.

New onset diabetes and atypical antipsychotics.

Liebzeit KA, Markowitz JS, Caley CF.

Eur Neuropsychopharmacol. 2001 Feb;11(1):25-32. Review.

PMID:
11226809
7.

The implications of weight changes with antipsychotic treatment.

Sussman N.

J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S21-6. Review.

PMID:
12832946
8.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
9.

Atypical antipsychotics and diabetic ketoacidosis: a review.

Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ.

Psychopharmacology (Berl). 2013 Mar;226(1):1-12. doi: 10.1007/s00213-013-2982-3. Epub 2013 Jan 24. Review.

PMID:
23344556
10.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
11.

Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.

Citrome LL, Holt RI, Zachry WM, Clewell JD, Orth PA, Karagianis JL, Hoffmann VP.

Ann Pharmacother. 2007 Oct;41(10):1593-603. Epub 2007 Sep 4. Review.

PMID:
17785613
12.

[Diabetes mellitus type II--induced by "atypical" neuroleptics?].

Wetterling T.

Fortschr Neurol Psychiatr. 2003 Jun;71(6):312-22. Review. German.

PMID:
12796851
13.

Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Henderson DC.

CNS Drugs. 2002;16(2):77-89. Review.

PMID:
11825099
14.
15.

[Diabetes mellitus associated with atypical antipsychotic medications: case report and review of the literature].

Reis JS, Alvarenga T, Rosário PW, Menezes PA, Rocha Rdos S, Purisch S.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):488-93. Review. Portuguese.

16.

Relationship of atypical antipsychotics with development of diabetes mellitus.

Citrome LL, Jaffe AB.

Ann Pharmacother. 2003 Dec;37(12):1849-57. Review.

PMID:
14632602
17.

[Risk of type 2 diabetes mellitus among users of atypical antipsychotic drugs or conventional treatment: systematic review and meta-analysis].

Sapunar Z J, Muñoz N S, Vásquez A T.

Rev Med Chil. 2009 Nov;137(11):1417-26. doi: /S0034-98872009001100002. Epub 2010 Jan 13. Review. Spanish.

18.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
19.

Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.

Ramaswamy K, Masand PS, Nasrallah HA.

Ann Clin Psychiatry. 2006 Jul-Sep;18(3):183-94. Review.

PMID:
16923657
20.

Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Henderson DC.

Curr Diab Rep. 2002 Apr;2(2):135-40. Review.

PMID:
12643133

Supplemental Content

Support Center